Bubs Australia (BUB.AX) Stock Price
Bubs Australia Price
Revenue has compounded at 92.9% per year over the past 19 years to 111.86 M AUD. Earnings per share have declined at 20.3% per year over the last 17 years. Bubs Australia's net margin stands at -4.1%, up from -12.7% several years earlier. Analysts set a median price target of 0.18 AUD, implying 74.9% above the current price. Of 7 analysts, 5 rate the stock a buy — an overall Buy consensus.
Bubs Australia stock price
Bubs Australia business model & stock analysis
Frequently asked questions about Bubs Australia
The business model of Bubs Australia Ltd revolves around the production and distribution of Australian-made infant formula and other premium baby food products. Bubs Australia focuses on organic and natural ingredients, ensuring high quality and nutritional value for babies and toddlers. The company has developed a strong presence in both domestic and international markets, targeting health-conscious parents who prioritize the well-being of their children. With a commitment to innovation and ongoing research, Bubs Australia aims to continue expanding its product range and strengthening its brand globally.
Bubs Australia Ltd is primarily active in the infant formula and baby food industry.
The main competitors of Bubs Australia Ltd in the market include Bellamy's Australia Ltd and a2 Milk Company Ltd. These companies are also known for their presence in the infant formula and baby food industry.
Bubs Australia Ltd, a leading infant nutrition company, has an impressive history and background. Founded in 2006, the company has grown exponentially to become a trusted provider of premium goat milk-based infant formula and organic baby food products. Bubs Australia Ltd focuses on producing high-quality, nutritious products sourced from Australian goat and cow milk. With a commitment to sustainable farming practices, the company has built strong partnerships with local farmers and suppliers. Bubs Australia Ltd's dedication to innovation and quality has earned them a strong market presence both domestically and internationally. As a result, the company continues to thrive and expand its product portfolio, catering to the evolving needs of parents worldwide.
Bubs Australia Ltd has achieved several significant milestones throughout its journey. The company experienced remarkable growth in recent years, expanding its product portfolio and market presence. Bubs successfully established partnerships with major retailers, both domestically and internationally, strengthening its brand recognition and consumer reach. Furthermore, Bubs Australia Ltd obtained coveted regulatory approvals, such as China's CNCA accreditation, enabling it to export infant formula to China. The company's commitment to innovation and quality has attracted a loyal customer base. Bubs Australia Ltd continues to strive for excellence and aims to deliver exceptional products to support the health and nutrition of children globally.
Bubs Australia Ltd is primarily present in various countries and regions. The company has a strong presence in Australia, its home country, where it originated. Additionally, Bubs Australia Ltd has expanded its reach to other regions, including China, where it has experienced significant growth and established partnerships with e-commerce platforms. The company's products, such as infant formula and organic baby food, have gained popularity among consumers in these markets, contributing to its presence and success.
Bubs Australia Ltd represents values and a corporate philosophy centered around providing premium and safe nutritional products for infants and children. The company is committed to using only high-quality, natural ingredients sourced from Australia. Bubs also values sustainability and ethical practices, aiming to reduce its environmental impact throughout its supply chain. With a strong focus on research and innovation, Bubs seeks to continuously improve its products and meet the evolving needs of parents and caregivers. The company's dedication to quality and transparency has made it a trusted brand in the infant nutrition market.
Analysts currently set an average price target of 0.18 AUD for the Bubs Australia stock (median: 0.18 AUD), implying +71.7 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Bubs Australia stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Bubs Australia share trades at 0.07 EUR (0.10 AUD).
The Bubs Australia share (BUB.AX) is listed on 1 stock exchanges, including: ASX (BUB.AX).
Bubs Australia Ltd is a leading manufacturer of high-quality organic baby food and baby care products in Australia. The company was founded in 2006 and is headquartered in Sydney.
The revenue of Bubs Australia is 111.86 M AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Bubs Australia is -4.62 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Bubs Australia is currently -20.29. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bubs Australia stock.
The price-to-sales ratio (P/S) of Bubs Australia is currently 0.84. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bubs Australia stock.
The Eulerpool Quality Score for Bubs Australia is 3/10.
The ISIN of Bubs Australia is AU000000BUB7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Bubs Australia is A2DJWZ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Bubs Australia is BUB.AX. The ticker symbol is used to trade Bubs Australia shares on the stock exchange.
Bubs Australia stock
Bubs Australia Peer Group
Bubs Australia Ticker
Bubs Australia FIGI
All fundamentals and in-depth analysis of Bubs Australia
Our stock analysis for Bubs Australia stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bubs Australia. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.